Arseus sees big drug compounding buys after U.S. add-on

BRUSSELS Thu Dec 20, 2012 4:41pm IST

Related Topics

Stocks

   

BRUSSELS (Reuters) - Belgo-Dutch medical supplies company Arseus has lined up big acquisitions early in 2013 to boost its pharmaceutical ingredients business after the latest in a string of smaller bolt-on purchases.

The specialist in supplying ingredients for medical compounding, allowing pharmacists to make their own versions of drugs, announced the relatively small purchase on Thursday of Colorado-based B&B Pharmaceuticals.

It followed three acquisitions last month worth a total of about 16.5 million euros ($21.88 million).

"We are fully involved with numerous other acquisition candidates and there are a small amount of big acquisitions coming up if all our plans succeed at the beginning of next year," Chief Executive Ger van Jeveren told a conference call for analysts.

He said the bigger acquisitions, which could be in the United States, Europe or South America, the main markets where Arseus operates, would be worth significantly more than those it made last month, but declined to elaborate.

Arseus, which also sells dentist chairs and surgical equipment, has 75 million euros to spend on making acquisitions, minus the cost of buying Colorado-based B&B Pharmaceuticals, which was announced on Thursday.

It declined to give a value for the B&B deal, saying only it paid 5.5 times core profit for the company, which it forecast would have turnover of about $6 million in 2012.

(Reporting By Ben Deighton; Editing by Hans-Juergen Peters and Mike Nesbit)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Ebola Outbreak

HEALTH SHOWCASE

E-cigarettes

E-cigarettes

WHO urges stiff regulatory curbs on e-cigarettes.  Full Article 

Weighty Issues

Weighty Issues

More parents think their overweight child is 'about right'.  Full Article 

Cancer Drug

Cancer Drug

Pfizer to test Xalkori lung cancer drug with Merck immunotherapy.  Full Article 

Mental Health

Mental Health

Obama tells veterans better mental health care on the way.  Full Article 

Food Regulation

Food Regulation

Russian food safety regulator shuts fifth McDonald's restaurant.  Full Article 

Heinz Recall

Heinz Recall

Heinz recall brings food tracking issue to the fore in China.  Full Article 

Delaying Start

Delaying Start

Delay morning school start for teens: pediatricians.  Full Article 

Birth Control

Birth Control

U.S. moves to ensure birth control access at religious companies.  Full Article